Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Role of the complement in experimental sepsis.

Peter A Ward1

  • 1University of Michigan Medical School, 1301 Catherine Road, Ann Arbor, MI 48109-0602, USA. pward@umich.edu

Journal of Leukocyte Biology
|September 19, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Extracellular Histones Associate with Blood-Brain Barrier Disruption and Astrocyte-Mediated Neuroinflammation During Polymicrobial Sepsis.

International journal of molecular sciences·2026
Same author

The Impact of Extracellular Histones and Absence of Toll-like Receptors on Cardiac Functional and Electrical Disturbances in Mouse Hearts.

International journal of molecular sciences·2024
Same author

Externalized histones fuel pulmonary fibrosis via a platelet-macrophage circuit of TGFβ1 and IL-27.

Proceedings of the National Academy of Sciences of the United States of America·2023
Same author

THE IMMUNOPATHOGENESIS OF POLYMICROBIAL SEPSIS.

Shock (Augusta, Ga.)·2022
Same author

Differential inflammatory responses of the native left and right ventricle associated with donor heart preservation.

Physiological reports·2021
Same author

Role of Complement and Histones in Sepsis.

Frontiers in medicine·2021
Same journal

Correction to: IL-27 signaling negatively regulates FcɛRI-mediated mast cell activation and allergic response.

Journal of leukocyte biology·2026
Same journal

Autofluorescence enables detection and quantification of EETosis in human leukocyte cultures.

Journal of leukocyte biology·2026
Same journal

Cold Atmospheric Plasma as an Immunomodulator: Suppression of T-cell Hyperactivation and Graft-versus-Host Disease via Redox Regulation.

Journal of leukocyte biology·2026
Same journal

Distinct lymphocyte immune signatures to nivolumab and recombinant IL-7 ex vivo in patients with sepsis.

Journal of leukocyte biology·2026
Same journal

Eosinophil Essentials: Identification and Assessment of Activity.

Journal of leukocyte biology·2026
Same journal

Immune cell landscape reveals 5 immune-related subtypes and molecular characteristics with prognostic and therapeutic implications in pan-cancer.

Journal of leukocyte biology·2026
See all related articles

Complement activation products and receptors play a key role in sepsis. Blocking C5a or C5a receptors improves survival in experimental sepsis and may be effective in human septic shock.

Area of Science:

  • Immunology
  • Sepsis Pathophysiology

Background:

  • Complement activation products and receptors are implicated in sepsis.
  • Experimental sepsis models show complement system involvement.

Purpose of the Study:

  • To investigate the role of complement activation products and receptors in experimental and human sepsis.
  • To assess the therapeutic potential of targeting C5a or C5a receptors in sepsis.

Main Methods:

  • Utilized cecal ligation and puncture (CLP) model in rodents.
  • Analyzed complement activation products (C3a, C5a) and C5a receptor (C5aR) expression in plasma and tissues.
  • Evaluated the effect of C5a or C5aR blockade on survival and immune function.

Main Results:

  • CLP induces complement consumption and C5a generation in rodents.

Related Experiment Videos

  • Sepsis up-regulates C5a receptors on neutrophils and in organs, with decreased expression correlating with mortality.
  • Interception of C5a or C5aR improves survival, preserves neutrophil function, and reduces coagulopathy in CLP.
  • Conclusions:

    • Complement activation and C5a/C5aR pathways are critical in sepsis pathophysiology.
    • Targeting C5a or C5aR demonstrates therapeutic efficacy in experimental sepsis.
    • Findings suggest potential clinical utility of C5a/C5aR blockade in human septic shock.